Equity Analysis

Quarterly Results

    Adline Chem Lab Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524604
    INE276T01018
    -2.7039316
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    9.51
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2024Sep 2024Jun 2024
Gross Sales0.000.000.00
Other Operating Income0.000.000.00
Other Income 0.000.000.00
Total Income0.000.000.00
Total Expenditure 0.100.070.10
PBIDT-0.10-0.07-0.10
Interest 0.030.030.03
PBDT-0.13-0.10-0.13
Depreciation0.000.000.00
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.01-0.01-0.01
Reported Profit After Tax-0.12-0.09-0.13
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-0.12-0.09-0.13
EPS (Unit Curr.)-0.02-0.02-0.02
EPS (Adj) (Unit Curr.)-0.02-0.02-0.02
Calculated EPS (Unit Curr.)-0.21-0.16-0.22
Calculated EPS (Adj) (Unit Curr.)-0.21-0.16-0.22
Calculated EPS (Ann.) (Unit Curr.)-0.84-0.63-0.86
Calculated EPS (Adj) (Ann.) (Unit Curr.)-0.84-0.63-0.86
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity5.855.855.85
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)0.000.000.00
PBDTM(%)0.000.000.00
PATM(%)0.000.000.00
Dividend Per Share(Rs)0.000.000.00
Diluted EPS-0.02-0.02-0.02